Open Access

Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo

  • Authors:
    • Dongliang Wang
    • Jingru Zhou
    • Cungang Fan
    • Feng Jiao
    • Bo Liu
    • Peng Sun
    • Junjie Miao
    • Qingjun Zhang
  • View Affiliations

  • Published online on: October 31, 2013     https://doi.org/10.3892/or.2013.2826
  • Pages: 41-49
  • Copyright: © Wang et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Leucine-rich repeat containing G protein-coupled receptor 5 (LGR5), one of the target genes of the Wnt signaling pathway, has recently been identified as a marker for brain cancer stem-like cells. However, the role of LGR5 in glioma is poorly understood. The aim of the present study was to investigate the relationship between LGR5 expression and pathological grade in glioma, and the impact of LGR5 on the proliferation of glioma cells in vitro and in vivo. Firstly, LGR5 expression was immunohistochemically evaluated in 54 resected gliomas of different pathologic grades, and its association with Ki-67 was evaluated. Subsequently, using western blotting and qRT-PCR, the expression of LGR5 was assessed in three glioma cell lines U87, U118 and U251. Moreover, the effects of LGR5 knockdown by siRNA on glioma cell proliferation, cell cycle, clone formation and tumorsphere formation in vitro and gliomagenesis in vivo were assessed. The results revealed that i) LGR5 was positively expressed in all glioma specimens and its expression increased with pathologic grade and Ki-67 expression; ii) LGR5 was highly expressed in three glioma cell lines and its expression was reduced significantly by siRNA; and iii) RNAi-mediated downregulation of endogenous LGR5 in U87 cells resulted in the suppression of cell proliferation, arrest of the cell cycle, and reduction in clone and tumorsphere formation in vitro. In addition, LGR5 depletion significantly inhibited tumor orthotopic xenograft growth in nude mice. These findings indicate that LGR5 plays a major role in gliomagenesis by promoting neoplastic cell proliferation, suggesting LGR5 as a molecular marker for pathology and a novel therapeutic target for malignant glioma.
View Figures
View References

Related Articles

Journal Cover

January 2014
Volume 31 Issue 1

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
APA
Wang, D., Zhou, J., Fan, C., Jiao, F., Liu, B., Sun, P. ... Zhang, Q. (2014). Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo. Oncology Reports, 31, 41-49. https://doi.org/10.3892/or.2013.2826
MLA
Wang, D., Zhou, J., Fan, C., Jiao, F., Liu, B., Sun, P., Miao, J., Zhang, Q."Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo". Oncology Reports 31.1 (2014): 41-49.
Chicago
Wang, D., Zhou, J., Fan, C., Jiao, F., Liu, B., Sun, P., Miao, J., Zhang, Q."Knockdown of LGR5 suppresses the proliferation of glioma cells in vitro and in vivo". Oncology Reports 31, no. 1 (2014): 41-49. https://doi.org/10.3892/or.2013.2826